These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 6930014)
1. Report to the Minister of Health of an investigation into allegations of an association between human congenital defects and 2,4,5-T spraying in and around Te Kuiti. N Z Med J; 1980 Apr; 91(658):314-5. PubMed ID: 6930014 [No Abstract] [Full Text] [Related]
2. Preliminary report of reproductive outcomes among pesticide applicators using 2,4,5-T. Smith AH; Matheson DP; Fisher DO; Chapman CJ N Z Med J; 1981 Mar; 93(680):177-9. PubMed ID: 6941101 [No Abstract] [Full Text] [Related]
3. The herbicide 2.4.5.-t and its possible dysmorphogenic effects. Sare WM; Forbes PI N Z Med J; 1977 May; 85(588):439. PubMed ID: 271842 [No Abstract] [Full Text] [Related]
4. Aerial spraying of 2,4,5-T and human birth malformations: an epidemiological investigation. Hanify JA; Metcalf P; Nobbs CL; Worsley KJ Science; 1981 Apr; 212(4492):349-51. PubMed ID: 7209535 [TBL] [Abstract][Full Text] [Related]
6. 2,4,5-T use and congenital malformation rates in Hungary. Thomas HF Lancet; 1980 Jul; 2(8187):214-5. PubMed ID: 6105388 [No Abstract] [Full Text] [Related]
7. Possible dysmorphogenic effects of an agricultural chemical: 2.4.5-T. Sare WM; Forbes PI N Z Med J; 1972 Jan; 75(476):37-8. PubMed ID: 4502634 [No Abstract] [Full Text] [Related]
8. Congenital defects and miscarriages among New Zealand 2, 4, 5-T sprayers. Smith AH; Fisher DO; Pearce N; Chapman CJ Arch Environ Health; 1982; 37(4):197-200. PubMed ID: 7114899 [TBL] [Abstract][Full Text] [Related]
9. Fetotoxicity. N Z Med J; 1972 May; 75(480):304-5. PubMed ID: 4503620 [No Abstract] [Full Text] [Related]
10. Dispute over some herbicides rages in wake of Agent Orange. Gunby P JAMA; 1979 Apr; 241(14):1443-4. PubMed ID: 430672 [No Abstract] [Full Text] [Related]
11. The agent orange controversy. McDaniel HG Ala J Med Sci; 1980; 17(3-4):256-7. PubMed ID: 7435859 [No Abstract] [Full Text] [Related]
12. Possible association between different congenital abnormalities and use of different sulfonamides during pregnancy. Czeizel AE; Puhó E; Sørensen HT; Olsen J Congenit Anom (Kyoto); 2004 Jun; 44(2):79-86. PubMed ID: 15198720 [TBL] [Abstract][Full Text] [Related]
14. Safe as 2, 4, 5-T? Thomas HF; Czeizel A Nature; 1982 Jan; 295(5847):276. PubMed ID: 7057891 [No Abstract] [Full Text] [Related]
15. [Congenital defects and drugs of noninstitutional use]. Villalbí JR Med Clin (Barc); 1999 Jan; 112(2):57-8. PubMed ID: 10065431 [No Abstract] [Full Text] [Related]
16. [A risk analysis of congenital defects due to drug intake during pregnancy. Spanish Collaborative Study of Congenital Malformations]. Martínez-Frías ML Med Clin (Barc); 1999 Jan; 112(2):41-4. PubMed ID: 10065427 [TBL] [Abstract][Full Text] [Related]
17. Valproic acid embryopathy: report of two siblings with further expansion of the phenotypic abnormalities and a review of the literature. Kozma C Am J Med Genet; 2001 Jan; 98(2):168-75. PubMed ID: 11223853 [TBL] [Abstract][Full Text] [Related]
18. Pesticides, health and ecology. Hickling S N Z Med J; 1974 Feb; 79(508):657-9. PubMed ID: 4522831 [No Abstract] [Full Text] [Related]
19. Antipodean 2,4,5-T. Hall P; Selinger B; Field B; Kerr C Nature; 1981 Mar; 290(5801):8. PubMed ID: 7207589 [No Abstract] [Full Text] [Related]
20. Responsibility of individual scientists. Waelsch SG Ann N Y Acad Sci; 1972; 196(4):241-6. PubMed ID: 4504115 [No Abstract] [Full Text] [Related] [Next] [New Search]